Eli Lilly & Co. (LLY)
Last updated: 2026-11-05 23:48:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,367.06, with a market capitalization of $1.26T and a P/E ratio of 45.52. Over the past 52 weeks, its price has ranged from $850.51 to $1,452.48. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.26T | |
$1,434.00 | |
$1,452.48 | |
$27.21 | |
$1,417.99 | |
3.96M | |
2.49M | |
45.52 | |
$1,452.48 | |
$850.51 | |
0.48% | |
2001-12-30 |
Eli Lilly & Co. (LLY) After-Hours Stock Price
Eli Lilly & Co. (LLY) is trading at $1,359.05 in after-hours trading as of 2026-11-05 23:32:20, down 4.16% ($58.94) from the regular-session close of $1,417.99.
After-hours trading shows how investors are pricing LLY after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Eli Lilly & Co. (LLY) 7-Day Stock Price Change
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,281.91 to $1,367.06, representing a gain of 6.64% ($85.15).
The stock traded between $1,260.34 and $1,452.48 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 3.39 million shares, up versus the previous seven-day period, indicating higher trading activity.
LLY 52-Week Price Position
Position in Range: 85.8%
LLY is currently trading at $1,367.06, placing it 85.8% of the way from its 52-week low of $850.51 to its 52-week high of $1,452.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Eli Lilly & Co. (LLY)?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly & Co. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| CEO | David A. Ricks |
| Founded | 1876 |
| Exchange | NYSE |
| Company Website |
How to Buy Eli Lilly & Co. (LLY) Stock on MEXC
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Eli Lilly & Co. (LLY) stock price today?
2.Is LLY stock going up or down today?
3.What is LLY pre-market price?
4.What is LLY after-hours price?
5.Is LLY stock trading now?
6.Where does LLY sit relative to its 52-week high and low?
7.What sector is Eli Lilly & Co. in?
8.What is Eli Lilly & Co.'s market capitalization and where is it listed?
9.How is LLY valued in terms of P/E ratio and EPS?
10.Does Eli Lilly & Co. pay a dividend?
Explore More US Stocks
Search Stocks
LLY Stock Calculator
Estimate the value between LLY shares and USD.
LLY Shares to USD
1.00 LLY shares = 1,367.064 USD
Calculations are estimates based on the latest available price and are for reference only.


